美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
46708-324-30	46708-324	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	125 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-324-30)
46708-325-30	46708-325	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	250 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-325-30)
46708-326-30	46708-326	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	500 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-326-30)
62332-325-30	62332-325	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	250 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-325-30)
62332-326-30	62332-326	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	500 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-326-30)
62332-324-30	62332-324	HUMAN PRESCRIPTION DRUG	Deferasirox	Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121	N/A	ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	125 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-324-30)